MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)
Status:
Completed
Trial end date:
2008-02-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of an investigational
drug in patients with Type 2 Diabetes Mellitus (T2DM) (a specific type of diabetes).